Vitamin E with Tocotrienol. Some research suggests tocotrienols are more potent in their anti-oxidation and healthy immune effects than the common forms of tocopherol due to significant differences in chemical structure. Gamma Tocotrienol is the only form of Vitamin E known to support healthy cholesterol levels.
![]() |
||
![]() |
![]() |
|
| Selenium | 70 mcg | 100 |
| Vitamin E (natural) | 210 IU | 700 |
| Alpha Tocotrienol | 12 mg | ** |
| Gamma Tocotrienol | 12 mg | ** |
| Oryza Oil Concentrate (from Rice Bran) | 170 mg | ** |
|
* Percent Daily Values (DV) are based on a 2000 calorie diet. ** Daily value not established |
||
Both tocotrienols and tocopherols, whose derivatives are in eight different isoforms, belong to vitamin E. However, some research suggests tocotrienols are more potent in their anti-oxidation and anti-cancer effect than the common forms of tocopherol due to significant differences in chemical structure. The unsaturated side-chain in tocotrienols makes them penetrate tissues with saturated fatty layers more efficiently, making them potentially more useful for cosmetic products.
While tocopherols are generally present in common vegetable oils (i.e. soy, canola), tocotrienols, on the other hand, are concentrated in cereal grains (ie. oat, barley, and rye, rice bran), with the highest level found in crude palm oil. Commercial tocotrienols and tocopherols are mainly obtained from natural sources, such as palm or rice bran oil.
There are eight naturally occurring forms of vitamin E, four are tocopherols (alpha, beta, delta, and gamma) and four are tocotrienols (alpha, beta, delta, and gamma). The most commonly known form is d-alpha tocopherol, discovered in 1922 during studies related to fertility. Vitamin E has been extensively studied since that time for its role as a fat-soluble antioxidant, especially as it relates to reproductive, neurologic, cardiovascular, and immune system health.*In the peer-reviewed Stroke journal (Oct 2005), oral supplementation of a natural full spectrum palm tocotrienol complex to spontaneously hypertensive rats led to increased tocotrienols level in the brain. The rats supplemented with tocotrienols showed more protection against stroke-induced injury compared to controls (non-supplemented group). This study demonstrated that oral supplementation of the palm tocotrienol complex acts on key molecular checkpoints (c-Src and 12-Lipoxygenase) to protect against glutamate- and stroke-induced neurodegeneration and ultimately may protect against stroke in vivo. (Sen, CK, et al., “Neuroprotective Properties of the Natural Vitamin E Alpha-Tocotrienol”, Stroke, 2005; 36:e 144 – e 152)
Palm tocotrienol complex has been shown in a double-blind placebo controlled human study conducted at the Kenneth Jordan Heart Foundation (NJ,US) to have the ability to reverse arteriosclerosis. Palm tocotrienol complex has the ability to reverse arterial blockage of the carotid artery in Carotid Stenosis patients
Antioxidants include polyphenols, lipoic acid, carotenoids, and tocotrienols. These 'nutraceuticals' have demonstrated greater antioxidant and anti-cancer activity than what has been achieved previously in nutritional protocols and cosmetics formula. The benefits of tocotrienols reach from decreasing platelet aggregation (clumping of blood) to anti-inflammatory action and anti-cancer activity.
Tocotrienols show considerably superior antioxidant properties compared to dl-α-Tocopherol in clinical and experimental studies due to their better distribution in the fatty layers of the cell membrane. The tocotrienol unsaturated side chain allows for a more efficient penetration into saturated fatty layers of the brain and liver. In addition to the free radical scavenging effect, the antioxidant function of tocotrienols is also associated with lowering tumor formation, DNA damage and cell damage. Studies in animals explored the effects of long-term administration of tocotrienols on liver cancer. Supplementation of tocotrienols in rats induced with a potent liver cancer agent demonstrated that the tocotrienols prolonged the impact of the cancer agent. Cell damage to the liver was significant in the untreated group versus the tocotrienol treated group.[citation needed]
A study showed that tocotrienols are the components of vitamin E responsible for growth inhibition in human breast cancer cells in vitro as well as in vivo through estrogen-independent mechanisms. Tocotrienols can also affect cell homeostasis, possibly independently of their antioxidant activity.[1] Anti-cancer effects of α- and γ-tocotrienol have been reported, although δ-tocotrienol was verified to be the most effective tocotrienol in inducing apoptosis (cell death) in estrogen-responsive and estrogen-nonresponsive human breast cancer cells. A daily dose of 30 - 50 mg mixture of α- and γ-tocotrienols can reduce breast cancer risk, and a treatment plan for breast cancer should use higher dosage.[citation needed]
Investigation of the antiproliferative effect of tocotrienols in PC3 and LNCaP prostate cancer cells suggests that the transformation of vitamin E to CEHC is mostly a detoxification mechanism, useful to maintain the malignant properties of prostate cancer cells.[2]
The development of new cholesterol-lowering agents has been given more and more attention by pharmaceutical companies due to the strong relationship between cholesterol and atherosclerosis. Tocotrienols, especially δ- and γ-tocotrienols, were shown to be effective nutritional agents to treat high cholesterol in recent research programs. In particular, γ-tocotrienol appears to act on a specific enzyme called 3-hydroxy-3-methylglutaryl-coenzyme and suppressed the production of this enzyme, which results in less cholesterol being manufactured by liver cells.[citation needed]
The investigation of the cholesterol-lowering effects of tocotrienols in cholesterol-fed rabbits found that the cholesterol in plasma decreased following gamma-tocotrienol treatment (-22%) after 6 weeks. The decrease was mainly attributable to a reduction in LDL cholesterol (23%).[3]
Investigation of the intake of antioxidants for its ability to prevent type 2 diabetes shows that vitamin E intake was significantly associated with a reduced risk of type 2 diabetes. The relative risk (RR) of type 2 diabetes between the extreme quartiles of the intake was 0.69 (95% CI 0.51-0.94, P for trend=0.003). Intakes of alpha-tocopherol, gamma-tocopherol, delta-tocopherol, and beta-tocotrienol were inversely related to a risk of type 2 diabetes. Thus the development of type 2 diabetes may be reduced by the intake of antioxidants in the diet.[4]